ProQR (PRQR) Plunges as Lead Drug Fails in Phase II/III Study Posted byZacks Equity Research February 14, 2022 Leave a comment on ProQR (PRQR) Plunges as Lead Drug Fails in Phase II/III Study ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study.